N,N-Dimethylformamide--water (1/1) → HCID 58447743, compound
Reaction equation
[C:1]([N:4]1[CH2:9][CH2:8][N:7]([C:10]2[CH:11]=[CH:12][C:13]([NH:16][C:17](=[O:33])[CH2:18][C:19]3[CH:20]=[C:21](Cl)[C:22]([C:25]4[CH:30]=[CH:29][N:28]=[C:27]([CH3:31])[CH:26]=4)=[N:23][CH:24]=3)=[N:14][CH:15]=2)[CH2:6][CH2:5]1)(=[O:3])[CH3:2].[CH3:34][N:35](C=O)C.O>[C-]#N.[Zn+2].[C-]#N.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd].CC(P(C(C)(C)C)[C-]1C=CC=C1)(C)C.C1C=CC([C-]2C(C3C=CC=CC=3)=C(C3C=CC=CC=3)C(C3C=CC=CC=3)=C2C2C=CC=CC=2)=CC=1.[Fe+2]>[C:1]([N:4]1[CH2:9][CH2:8][N:7]([C:10]2[CH:11]=[CH:12][C:13]([NH:16][C:17](=[O:33])[CH2:18][C:19]3[CH:20]=[C:21]([C:34]#[N:35])[C:22]([C:25]4[CH:30]=[CH:29][N:28]=[C:27]([CH3:31])[CH:26]=4)=[N:23][CH:24]=3)=[N:14][CH:15]=2)[CH2:6][CH2:5]1)(=[O:3])[CH3:2]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 3
Conditions
- Temperature
- 130 °C
Procedure
To a sealed tube were added N-(5-(4-acetylpiperazin-1-yl)pyridin-2-yl)-2-(3-chloro-2′-methyl-2,4′-bipyridin-5-yl)acetamide 184 (46 mg, 0.10 mmol), zinc cyanide (14 mg, 0.12 mmol), Pd2(dba)3 (9 mg, 0.010 mmol), Q-phos (9 mg, 0.022 mmol) and 1 ml DMF/H2O (99/1, v/v). The reaction mixture was bubbled with nitrogen for 1 minute and stirred at 130° C. overnight. After cooling to room temperature, the solvents were evaporated and the crude product was purified by reverse phase HPLC to give N-(5-(4-acetylpiperazin-1-yl)pyridin-2-yl)-2-(3-cyano-2′-methyl-2,4′-bipyridin-5-yl)acetamide 188. MS m/z 456.2 (M+1); 1H NMR 400 MHz (MeOD) δ 8.85 (d, 1H), 8.56 (d, 1H), 8.28 (d, 1H), 7.98 (s, 1 Hz), 7.88 (d, 1H), 7.78 (s, 1H), 7.73-7.70 (m, 1 Hz), 7.39 (dd, 1H), 3.89 (s, 2H), 3.69 (t, 2H), 3.65 (t, 2H), 3.16 (t, 2H), 3.11 (t, 2H), 2.61 (s, 3H), 2.09 (s, 3H).
Workup
- customThe reaction mixture was bubbled with nitrogen for 1 minute
- temperatureAfter cooling to room temperature
- customthe solvents were evaporated
- customthe crude product was purified by reverse phase HPLC
Sources & evidence
- ORD record
- ord-97b89ba44c17409a99238b0a6098f9e2
- Source dataset
- uspto-grants-2013_10
- Patent number
- US08546396B2
Reaction notes
Loading…